我要投票 雷氏在珍珠粉行业中的票数:232
· 外 推 电 报 ·
2025-04-03 08:50:50 星期四

【雷氏是哪个国家的品牌?】

雷氏是什么牌子?「雷氏」是 上海雷允上药业有限公司 旗下著名品牌。该品牌发源于上海,由创始人苏俊英在1998-11-13期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力雷氏品牌出海!通过在本页面挂载雷氏品牌的产品链接和联系邮箱,可以提高雷氏产品曝光!跨境电商爆单神器,目前只要100元/年哦~

百年老字号雷允上药店始建于苏州,发迹于上海,迄今已有近三百年历史。公元1734年(清雍正十二年)创始于苏州;1860年(清咸丰十年)设“申号”于上海新北门外,1934年设“北号”于河南北路天后宫桥(今河南路桥)北堍,1937年又设北号支店于静安寺路(今南京西路)。由于药店规模较大,资产雄厚,影响面广,早年就被国药同业公认为上海中药店“四大户"之一。中国改革开放以来,经资产重组,工商联手,今日上海雷允上药业雄风再现,成为中国中药行业的强者。雷允上药业历史渊源>>

上海雷允上药业有限公司是上药集团上海市药材有限公司为投资主体成立的集农工商、科工贸、产学研于一体的大型中药企业,历年被认定为上海市高新技术企业、上海市文明单位,是上海市第一批知识产权示范企业,旗下“雷氏”品牌被认定为中国驰名商标,并以20.8亿的品牌价值荣获中国500最具价值品牌称号。近年来,公司及其品牌先后获得中国百年中药老字号企业、最具价值的上海老商标、上海市出口名牌、上海市装备制造业与高新技术产业自主创新品牌、上海现代服务业百强等荣誉称号。

公司拥有严格的质量保证体系。从中药产业链源头GAP规范标准入手,严格原药材采购控制。拥有国家GMP规范要求的中药产业化制造基地,能生产20多个剂型500多个品种。拥有包括中药材、中成药、保健品和名贵参茸等在内的强大的专业营销网络,辐射全国,足迹遍及东南亚、北美、欧洲等地。雷允上连锁多年被评为最具影响力特许品牌。六神丸、雷氏珍菊降压片、雷氏炮天红酒等产品历年被评为上海市名牌产品,在海内外均享有较高的声誉。多年坚持开展社区健康服务,2006年赢得了“全国卫生进社区——相约健康社区行”社会公益奖。

公司传承“至诚至信,关爱生命”的企业追求,竭尽所能地致力于服务社会、造福人类的伟大事业,为弘扬祖国优秀中医药文化,为人类的健康贡献力量。

英文翻译:The century old drugstore under leiyunshang pharmaceutical was founded in Suzhou and started in Shanghai. It has a history of nearly 300 years. It was founded in Suzhou in 1734 (the 12th year of Yongzheng reign in the Qing Dynasty); in 1860 (the 10th year of Xianfeng reign in the Qing Dynasty), it was set up outside the new North Gate of Shanghai; in 1934, it was set up in the north end of hougongqiao (now Henan Road bridge), North Henan Road; in 1937, it was set up in Jingansi Road (now Nanjing West Road). Due to the large scale, strong assets and wide influence of drugstores, they have been recognized as one of the "four big families" of Shanghai Traditional Chinese medicine stores by the pharmaceutical industry in the early years. Since China's reform and opening up, through asset restructuring and joint efforts of industry and commerce, the pharmaceutical industry of Shanghai leiyunshang Pharmaceutical Co., Ltd. has reappeared today, becoming a strong player in the Chinese traditional medicine industry. The history of pharmaceutical industry under leiyunshang pharmaceutical & gt; & gt; Shanghai leiyunshang Pharmaceutical Co., Ltd. is a large-scale traditional Chinese medicine enterprise established by Shanghai Pharmaceutical Group Co., Ltd. as the main investor, integrating agriculture, industry and commerce, science, industry and trade, production, learning and research. It has been recognized as a high-tech enterprise in Shanghai and a civilized unit in Shanghai. It is the first batch of intellectual property demonstration enterprises in Shanghai. Its "Leishi" brand is recognized as a well-known trademark in China Won the title of China's 500 most valuable brand with a brand value of 2.08 billion. In recent years, the company and its brand have successively won the honorary titles of China's century old brand enterprise of traditional Chinese medicine, the most valuable old trademark of Shanghai, Shanghai Export famous brand, independent innovation brand of Shanghai equipment manufacturing industry and high-tech industry, and top 100 modern service industry of Shanghai. The company has a strict quality assurance system. Starting from the gap standard of the source of traditional Chinese medicine industry chain, strictly control the purchase of original Chinese medicine. It has the industrialization manufacturing base of traditional Chinese medicine required by the national GMP standard, and can produce more than 20 dosage forms and more than 500 varieties. It has a strong professional marketing network including traditional Chinese medicine, Chinese patent medicine, health care products and rare ginseng antler, covering the whole country, covering Southeast Asia, North America, Europe and other places. Leiyunshang chain has been rated as the most influential franchise brand for many years. Liushenwan, Zhenju hypotensive tablet and Baotian red wine have been rated as famous brand products in Shanghai over the years, enjoying a high reputation at home and abroad. In 2006, it won the social public welfare award of "national health into the community - meeting healthy communities". The company inherits the enterprise pursuit of "sincere and trustworthy, caring for life", devotes itself to the great cause of serving the society and benefiting the human as much as possible, promotes the excellent traditional Chinese medicine culture of the motherland and contributes to the health of human beings.

本文链接: https://www.waitui.com/brand/942bfee42.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

正力新能香港IPO今起招股,预计4月14日上市

36氪获悉,正力新能在港交所公告,公司拟全球发售约1.22亿股H股,香港发售股份1215.24万股,国际发售股份约1.09亿股,另有约15%的超额配股权;2025年4月3日至4月9日招股;发售价为每股8.27港元,每手买卖单位为300股;预期股份将于2025年4月14日开始在香港联交所买卖。

51分钟前

返投比例低至零点四倍,创投机构投资限制再松绑

近日,长沙经开集团出资设立的科创母基金完成备案,值得关注的是,该基金将总体返投要求设置为0.4倍,这对于以往动辄2倍、3倍的返投比例而言,已然大幅下降。据了解,近年来,各地国资已成为创投机构募资的主要来源,但同时因为国资的特殊地位,对创投机构也有颇多限制,较高的返投比例就是其中之一。但随着国资母基金的日渐市场化,返投比例正在持续下降,将再度激发创投机构的投资热情。(证券时报)

51分钟前

供需两端高效促消费,财政政策“后手”力度可期

近日,中办、国办印发的《提振消费专项行动方案》(下称《方案》)与今年更加积极的财政政策同向发力,要求“发挥财政政策引导带动作用”,将促消费同惠民生、补短板结合起来。受访专家学者认为,《方案》已部署的各项举措将发挥财政资金“四两拨千斤”的作用,在短期激发居民消费潜力,在中长期改善居民消费能力。目前,更加积极的财政政策尚有较为充足的政策空间,未来提振消费还可以在补贴力度、税费减免等方面进一步谋划增量政策,推动新一轮财税体制改革也将改善消费环境。(证券时报)

51分钟前

亚马逊最快下周发射首批Kuiper卫星,预计年内开始提供互联网服务

亚马逊当地时间4月2日宣布,计划不早于当地时间4月9日在美国佛罗里达州发射首批27颗Kuiper卫星,以全面部署卫星互联网网络。亚马逊表示,预计今年晚些时候将开始向客户提供服务。亚马逊的Kuiper计划目标将超3200颗卫星送入近地轨道。(界面)

51分钟前

跨境投资与境外融资业务齐头并进,头部券商国际化业务高速增长

近年来,国际业务成为券商业绩的重要增长极。2024年,券商国际业务营收前四名分别是华泰国际、中信证券国际、中金国际和国泰君安金融控股。除中金国际外,其他三家同比营收增速都超过40%。业内人士认为,去年境外股权融资业务、中资离岸债业务为券商国际化提供了战略机遇。同时,部分头部券商围绕权益、指数、利率、汇率、商品等标的,为境内外客户提供综合金融服务,满足了客户全球化资产配置和分散化风险管理的业务需求。部分券商还通过加强高评级、高流动性固定收益资产的配置力度,提升了整体业绩。(上证报)

51分钟前

本页详细列出关于雷氏的品牌信息,含品牌所属公司介绍,雷氏所处行业的品牌地位及优势。
咨询